Arax Advisory Partners’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$228K Buy
+11,685
New +$232K ﹤0.01% 2164
2026
Q1
Sell
-2,228
Closed -$42.2K 4257
2025
Q4
$42.2K Sell
2,228
-10,302
-82% -$191K ﹤0.01% 1702
2025
Q3
$234K Buy
12,530
+12,243
+4,266% +$229K ﹤0.01% 1190
2025
Q2
$5.29K Buy
287
+239
+498% +$4.24K ﹤0.01% 2233
2025
Q1
$839 Hold
48
﹤0.01% 2361
2024
Q4
$832 Hold
48
﹤0.01% 2209
2024
Q3
$894 Buy
+48
New +$809 ﹤0.01% 2291
2023
Q4
Sell
-136
Closed -$1.9K 1409
2023
Q3
$1.9K Buy
136
+79
+139% +$1.01K ﹤0.01% 1017
2023
Q2
$671 Buy
+57
New +$649 ﹤0.01% 1170
2022
Q3
Sell
-38
Closed -$1K 1259
2022
Q2
$1K Sell
38
-246
-87% -$3.29K ﹤0.01% 1110
2022
Q1
$4K Buy
284
+136
+92% +$1.86K ﹤0.01% 844
2021
Q4
$2K Buy
148
+110
+289% +$1.56K ﹤0.01% 923
2021
Q3
$1K Buy
+38
New +$642 ﹤0.01% 938

Other funds holding SBRA

Arax Advisory Partners's SBRA Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Sabra Healthcare REIT (SBRA) in Q2 2026: 11,685 shares worth $228K. The stake represents ﹤0.01% of the portfolio and ranks #2164 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in SBRA as recently as Q4 2025.

Arax Advisory Partners first reported a position in SBRA in Q3 2021 and has held it in 13 quarters since. The position peaked at $234K in Q3 2025. 463 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Arax Advisory Partners held 11,685 shares of Sabra Healthcare REIT worth $228K as of Q2 2026.
  • Sabra Healthcare REIT was a new Arax Advisory Partners position in Q2 2026.
  • Sabra Healthcare REIT made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2164 holding.
  • Arax Advisory Partners first reported a position in Sabra Healthcare REIT in Q3 2021 and has held it in 13 quarters since.
  • Arax Advisory Partners's Sabra Healthcare REIT position peaked at $234K in Q3 2025.
  • 463 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.